| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/10/2002 | WO2001046455A3 Survivin promotion of angiogenesis |
| 05/10/2002 | WO2001042425A3 Lung stem cells and lung regeneration |
| 05/10/2002 | WO2001036487A3 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/10/2002 | WO2001035990A3 Method for enhancing t cell reactivity toward tumour antigens |
| 05/10/2002 | WO2001032709A3 Polypeptides with non-natural primary signalling motifs |
| 05/10/2002 | WO2001025271A3 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 05/10/2002 | WO2001001976A3 Composition comprising an extract of perna canaliculus, methylsulfonylmethane and glucosamine |
| 05/10/2002 | WO2001000246A3 Hydrogels derived from chitosan and poly(ethylene glycol) |
| 05/10/2002 | WO2000067761A8 Compositions and methods for identifying antigens which elicit an immune response |
| 05/10/2002 | WO2000054802A3 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization |
| 05/10/2002 | WO2000042208A8 Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use |
| 05/10/2002 | CA2463623A1 Epitope-beta microglobulin polynucleotide for anti-cancer immunotherapy |
| 05/10/2002 | CA2431332A1 Compositions and methods for prolonging survival of chilled platelets |
| 05/10/2002 | CA2427537A1 Use of enzymes obtained from ciliates as medicaments for promoting digestion |
| 05/10/2002 | CA2427257A1 Expression vectors able to elicit improved immune response and methods of using same |
| 05/10/2002 | CA2426987A1 Human cord blood derived unrestricted somatic stem cells (ussc) |
| 05/10/2002 | CA2426819A1 Tissue-engineered vascular structures |
| 05/10/2002 | CA2426658A1 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries |
| 05/09/2002 | US20020056149 Regenerating animal embryo; obtain cell, transfer diploid nucleus into cell, activate, recover viable infant |
| 05/09/2002 | US20020056148 Generating vertebrate geneticaly engineered stem cells; administer transfection mixture into gonad, allow vector insertion into genome, monitor germ cells for expression of marker |
| 05/09/2002 | US20020055489 Interleukin-12 inducer and medical composition |
| 05/09/2002 | US20020055482 Molecular constructs with a carcinoembryonic antigen (cea) transcriptional regulatory sequence |
| 05/09/2002 | US20020055461 Stable polymer aqueous/aqueous emulsion system and uses thereof |
| 05/09/2002 | US20020055173 Plasmids for use in expressing heterologous proteins on surface viral particle and for use in gene therapy |
| 05/09/2002 | US20020055170 Process for producing and multiplying lymphocytes |
| 05/09/2002 | US20020055160 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/09/2002 | US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies |
| 05/09/2002 | US20020055122 Administering to the recipient mammal for promoting acceptance of graft, an inhibitor of the CD40/ ligand- CD40 costimulatory interaction; introducing into the recipient mammal, hematopoietic stem cells and implanting the graft |
| 05/09/2002 | US20020055090 Composition for density gradient cell separation |
| 05/09/2002 | US20020054917 Compositions comprising beta glucan and lactoferrin, and methods for their use |
| 05/09/2002 | US20020054916 Comprising ceruloplasmin and a serum-derived composition (SDF) having a low molecular weight, electrically charged at acidic pH and having absorption at 280 mn, capable of inducing terminal cell differentiation of leukemic cells |
| 05/09/2002 | US20020054901 Methods and compositions for bone graft implants |
| 05/09/2002 | US20020054885 Herpes simplex virus-1 Glycoprotein C mutants for treating unwanted hyperproliferative cell growth |
| 05/09/2002 | US20020054868 Bacterial strain, processes plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/09/2002 | US20020054867 A probiotic formulation of Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799); containing at least one volatile fraction (VF) of a plant extract |
| 05/09/2002 | US20020054866 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 05/09/2002 | US20020053510 Methods and apparatus for processing the surface of a microelectronic workpiece |
| 05/08/2002 | EP1203819A2 Anti-inflammatory vectors |
| 05/08/2002 | EP1203813A2 Attenuated pestiviruses |
| 05/08/2002 | EP1203812A2 Attenuated pestiviruses |
| 05/08/2002 | EP1203088A2 Conditionally controlled, attenuated hiv vaccine |
| 05/08/2002 | EP1203084A1 Microencapsulated nitric oxide synthase source |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1202750A1 Method of treating hiv infection and related secondary infections thereof |
| 05/08/2002 | EP1202744A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 05/08/2002 | EP0915648B1 Methods and compositions for the selective modification of nucleic acids |
| 05/08/2002 | DE10055705A1 Inhibiting rejection of transplanted organs by additionally transplanting rapidly dividing tissue, preferably stem cells, from the same donor |
| 05/08/2002 | DE10055703A1 Ex vivo blood lavage with oligomeric carbohydrates for removal of pathogens, hapten-containing antibody aggregates and amyloids, useful in treatment of e.g. multiple sclerosis and Alzheimer's disease |
| 05/08/2002 | DE10055700A1 Elimination of cancer or leukemia cells using active cell-destroying viruses having oligosaccharide haptens corresponding to the malignant cells |
| 05/08/2002 | DE10055697A1 Inhibiting onset of AIDS in HIV-positive patients, by adding oligomeric carbohydrates, identical with oligosaccharide haptens on the surface of T-lymphocytes, to serum |
| 05/08/2002 | CN1348497A 载体 Carrier |
| 05/08/2002 | CN1348496A Viral vaccine |
| 05/08/2002 | CN1348490A Method for the purification, recovery, and sporulation of cysts and oocysts |
| 05/08/2002 | CN1348463A Immunological herpes simplex virus antigens and methods for use thereof |
| 05/08/2002 | CN1347720A Hair moistening liquid with functions of nourishing hair, restoring hair, stopping baldness and eliminating scurf |
| 05/08/2002 | CN1347715A Hepatitis B recuperating medicine granule |
| 05/08/2002 | CN1347713A Anorexia treating oral liquid |
| 05/08/2002 | CN1347707A Externally applied bone Bi-syndrome treating plaster and its prepn |
| 05/08/2002 | CN1347703A Leukoderma treating externally-used medicine |
| 05/08/2002 | CN1347702A Mixed live bacillus drops of bifidobacterium and lactobacillaceau and its prepn |
| 05/08/2002 | CN1347701A Seahorse powder capsule |
| 05/08/2002 | CN1347700A Method of in vitro culturing medicine ox gallstone with natural ox gall |
| 05/08/2002 | CN1084210C Health mask for curing and preventing typhoid |
| 05/08/2002 | CN1084206C Medicine for treating cancer and its preparing method |
| 05/08/2002 | CN1084203C Health-care tortoise-turtle-pollen food |
| 05/08/2002 | CN1084200C Anticancer pill and its preparing process |
| 05/08/2002 | CN1084198C Chinese herbal medicine bolus for treating psoriasis |
| 05/08/2002 | CN1084197C Medicine for treating rheumatism, rheumatoid disease, hyperosteogeny and arthritis, and its preparing process |
| 05/08/2002 | CN1084196C Burn ointment |
| 05/08/2002 | CN1084194C Process for preparing ultramicro infant medicine |
| 05/08/2002 | CN1084193C Medicine for lowering blood-sugar and nourishing heart and preparing method |
| 05/07/2002 | US6384252 Fatty acids or derivatives; mammalian mammary glands secretion; stress, anxiety and aggression reduction |
| 05/07/2002 | US6384084 Histochrome and its therapeutic use in ophthalmology |
| 05/07/2002 | US6383807 Method of transforming T lymphocytes |
| 05/07/2002 | US6383780 2786, a novel human aminopeptidase |
| 05/07/2002 | US6383732 Method of preparing xenograft heart valves |
| 05/07/2002 | US6383529 Process and composition for controlling fecal hair excretion and trichobezoar formation |
| 05/07/2002 | US6383522 Toxicity reduced composition containing an anti-neoplastic agent and a shark cartilage extract |
| 05/07/2002 | US6383521 Sponge extract (wondonin a) with antiangiogenesis and anticarcinogenic properties; non-cytotoxic |
| 05/07/2002 | US6383496 Recombinant vaccines comprising immunogenic attenuated bacteria having RPOS positive phenotype |
| 05/07/2002 | US6383494 Heat shock proteins |
| 05/07/2002 | US6383493 Methods and compositions for eliciting an immune response with hsp70-peptide complexes |
| 05/07/2002 | US6383492 Treatment of infectious diseases with gp96-peptide complexes |
| 05/07/2002 | US6383491 Prevention of infectious diseases with hsp90-peptide complexes |
| 05/07/2002 | US6383482 Weight loss composition containing green tea, hydroxycitric acid, 5-hydroxytryptophan, glucomannan, picolinate and lactobacillus |
| 05/07/2002 | US6383481 Method for transplantation of hemopoietic stem cells |
| 05/07/2002 | US6383478 Polymeric encapsulation system promoting angiogenesis |
| 05/07/2002 | CA2223700C In ovo vaccination against coccidiosis |
| 05/07/2002 | CA2214503C Method for treating tumors |
| 05/02/2002 | WO2002034915A2 Preferred segments of neural thread protein and methods of using the same |
| 05/02/2002 | WO2002034903A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
| 05/02/2002 | WO2002034889A2 Therapeutic uses for mesenchymal stromal cells |
| 05/02/2002 | WO2002034888A1 Ex vivo oxidatively stressed cll cells in chronic lymphocytic leukemia (cll) treatment |
| 05/02/2002 | WO2002034885A1 Sericin-containing material, process for producing the same and method of using the same |
| 05/02/2002 | WO2002034786A1 Method of eliminating human serum albumin polymers |
| 05/02/2002 | WO2002034753A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2002034306A1 Surface modification of islet membranes by polymeric grafting methods |
| 05/02/2002 | WO2002034296A1 A novel gene therapy agent for haemophilia b and its preparation method |
| 05/02/2002 | WO2002034274A1 A composition or rose hip and fish oil for alleviating joint pain and stiffness |
| 05/02/2002 | WO2002034273A1 Compositions and methods for diagnosis and treatment of cardiovascular disorders |